Table 1.
Use of probiotics in several disorders.
| Disease | Probiotic | Reference |
|---|---|---|
| Acute diarrhea | Lactobacillus rhamnosus GG | [110] |
| Allergic rhinitis | Lactobacillus acidophilus L-92 | [111] |
| Antibiotic-associated diarrhea | Saccharomyces boulardii | [112] |
| Asthma | Enterococcus faecalis FK-23 | [113] |
| Atopic dermatitis | Lactobacillus paracasei, and Lactobacillus fermentum | [114] |
| Atopic eczema | Mixture (Bifidobacterium bifidum, Bifidobacterium lactis, and Lactobacillus acidophilus) | [115] |
| Bacterial vaginosis | Saccharomyces cerevisiae Lactobacillus acidophilus, Lactobacillus rhamnosus GR-1, and Lactobacillus fermentum RC-14 | [116] [117] |
| Cardiovascular disorder | Lactobacillus rhamnosus GG | [118] |
| Chronic diarrhea | Lactobacillus plantarum CCFM1143 | [119] |
| Colon cancer | Lactobacillus rhamnosus Lactobacillus acidophilus, Mixture (Bifidobacteria bifidum, and Bifidobacteria infantum) | [120] [121] |
| Crohn’s disease | Escherichia coli Nissle 1917 Saccharomyces boulardii | [122] [123] |
| Diabetes | Lactobacillus acidophilus | [124] |
| Diarrhea | Bifidobacterium bifidum FSDJN705, and Bifidobacterium breve FHNFQ23M3 | [125] |
| Gastroenteritis | Lactobacillus F19 | [126] |
| Hypercholesterolemia | Enterococcus faecium M-74 | [127] |
| Lactose intolerance | Lactobacillus acidophilus DDS-1 | [128] |
| Liver disorder | Escherichia coli Nissle VSL#3 | [129] [130] |
| Metabolic disorder | Bifidobacterium adolescentis Z25 | [131] |
| Obesity | Lactobacillus plantarum K50 | [132] |
| Urinary tract infections | Lactobacillus rhamnosus GR-a and Lactobacillus reuteri RC-14 | [133] |